Germany, France, Italy, and Spain have turn into the newest nations to droop utilizing the vaccine, becoming a member of Eire, Denmark, Thailand, the Netherlands, Norway, Iceland, Congo, and Bulgaria.
The European Medicines Company (EMA) mentioned suspending use of the AstraZeneca vaccine is “a precaution taken within the mild of their nationwide scenario.” However the EMA in addition to the World Well being Group mentioned knowledge doesn’t present the vaccine triggered the clots and folks ought to preserve getting vaccinated with it as a result of the profit outweighs the danger.
“Many thousands of people develop blood clots annually in the EU for different reasons. The number of thromboembolic events overall in vaccinated people seems not to be higher than that seen in the general population,” the EMA mentioned in a press release.
AstraZeneca defended the safety of the vaccine.
“Around 17 million people in the EU and UK have now received our vaccine, and the number of cases of blood clots reported in this group is lower than the hundreds of cases that would be expected among the general population,” Ann Taylor, chief medical officer, said in a news launch.
“The nature of the pandemic has led to increased attention in individual cases and we are going beyond the standard practices for safety monitoring of licensed medicines in reporting vaccine events, to ensure public safety.”
AstraZeneca says medical trials present its vaccine has an efficacy of about 70% in comparison with the 95% and 94% efficacy for the Pfizer and Moderna vaccines, respectively. All three are being utilized in Europe.
The World Well being Group licensed the AstraZeneca-College of Oxford vaccine on Feb. 15. That allowed the United Nations to distribute doses to low- and middle-income nations.
AstraZeneca says it plans to hunt emergency use authorization from the FDA quickly.